Cultivating hope one star sperm at a time
Improved success in ART
Spermotile improves the success rates of assisted reproductive technologies such as IUI, IVF and ICSI by as much as 20%.
Reduced pain and cost
Spermotile reduces the number of cycles per patient by improving the success rate of fertilization. This reduces both the pain and the cost of the treatment.
Star sperm selection
Spermotile uses a patent-pending technology to identify the best sperms in terms of morphology, motility, kinematics and nanoscale motion patterns in a chemical-free manner.
Infertility
As infertility rates rise globally, affecting 15% of couples, the demand for ART (Assisted Reproduction Technologies) has increased. But ART is demanding — physically, psychologically, and financially — with no guarantee of success. Selecting the highest quality sperm for fertilization can improve ART outcomes.
News & Award
Featured in Forbes India Leadership Award print issue(7th Mar’25)
A-list certificate and interview at leading news channel NewsX
Spermotile Founders Selected for EIC Women Leadership Program
Spermotile bags Asia’s Leading Brands and Leaders Award 2024 by Film Actress Vaani kapoor
Spermotile selected for Best Innovation in Fertility Technology by Business Connect
Spermotile reaches 4 Million Euros mark of public funding
Spermotile awarded the prestigious RCN Verification funding
Femina Achievers Award for Innovation in Fertility Treatment from Ex- Minister of State for External Affairs, India Ms. Meenakshi Lekhi
Spermotile featured in NordLys
Spermotile celebrates international women day
Spermotile awarded EIC transition grant, under lean success rate of <10%
Spermotile: only Norwegian application funded by EIC Transition 2024 calls
Research outcome published in Fertility & Science journal
AI based Sperm detection published in ICPR Workshop 2024
Funding, Partners & Stakeholder
EIC Transition 2025
Norway – RCN Verification 2025
EU ERC-POC 2023
Norway – RCN Qualification 2024
Norway – RCN Qualification 2023
Norway – RCN Verification 2024
Innovation Norway(REACH Program)
University Hospital North Norway
UiT Innovation support
TTO-Norrinova
Improve ART success rate with Spermotile
Presenting Spermotile: a game-changer in ART, aimed at boosting fertilization rates and minimizing treatment cycles. Spermotile’s groundbreaking computer-assisted semen analysis (CASA) identifies the top-quality sperms, termed ‘star sperms,’ without using harmful stains, which are then filtered by Spemotile’s non-chemical and extremely gentle patent pending technology’.
